AI-Stem Cell Researcher, Co-Founder@CTO

Minjun Kang

Hi! I am Minjun Kang, the CTO and Co-founder of NOAH’S FARM PTE. LTD. in Singapore, and a fully funded Ph.D. candidate in Medicine and Computer Science at Seoul National University, where I previously earned my Master of Medicine degree summa cum laude honors and an Excellent Thesis Honor. My research was recognized as one of the Top 5 flagship R&D achievements among Korea’s top 30 medical research outcomes. I also worked as a biomedical researcher at Seoul National University Hospital in Korea and hold a B.S. in Biomedical Sciences from CHA University.

AI, Stem Cell Engineer

To discern truth, humans rely on science—and so does AI.

  • -
    NOAH'S FARM PTE LTD (Singapore), Co-founder/CTO

    Responsible for the food flavor.

    https://www.noahs-farm.xyz/.

  • -
    Seoul National University Hospital (Korea), Biomedical Researcher

    I worked in the Cardiac Differentiation Team of the Cardiovascular Laboratory at the Biomedical Research Institute, with a focus that bridges computer science and stem cell biology.


    In computer science, my research centers on the generation of ligands targeting G protein–coupled receptors (GPCRs)—critical targets for stem cell therapeutics—using AI. This involves leveraging generative AI and drug discovery pipelines to identify and optimize novel therapeutic ligand candidates.


    In stem cell biology, I specialize in advanced cardiac differentiation protocols for both mouse embryonic stem cells and human-induced pluripotent stem cells (iPSCs). My expertise extends to the preservation of pluripotent stem cells, the development of lentiviral overexpression vectors, and the creation of conditional knockout transgenic mice for cardiovascular research.

  • -
    ALTERNATE, Founder, CEO

    I founded a cultured meat company dedicated to promoting human health through cellular agriculture. In 2022, the company was selected as a finalist in the National Development Project (Topic: Cultured Meat) organized by the Korean Chamber of Commerce and Industry. In the same year, we successfully completed the Startup Pre-School Program, validating our technological approach and business potential.

Research

Studied stem cells for my bachelor's degree, GPCRs for my master's, and generative AI models in medicine for my Ph.D. to discover heart-specific ligands.

  • Journals

    -

    1. Minjun Kang, Choon-Soo Lee, HyunJu Son, Jeongha Lee, Jaewon Lee, Hyun Ju Seo, Moo-kang Kim, Murim Choi, Hyun-Jai Cho, and Hyo-Soo Kim. Latrophilin-2 deletion in cardiomyocyte disrupts cell junction, leading to D-CMP -Circulation Research (Top-Ranked Journal in cardiovascular research, AHA Journal)

    2. Jin-Woo Lee, Choon-Soo Lee, HyunJu Son, Jaewon Lee, Minjun Kang, Jinho Chai, Hyun-Jai Cho, Hyo-Soo Kim. SOX17-mediated LPAR4 expression plays a pivotal role in cardiac development and regeneration after myocardial infarction -Experimental & Molecular Medicine (Nature Portfolio)

    3. Choon-Soo Lee, Hyun-Jai Cho, Jin-Woo Lee, Hyun Ju Son, Jaewon Lee, Minjun Kang, Hyo-Soo Kim. The G Protein-Coupled Receptor Latrophilin-2, A Marker for Heart Development, Induces Myocardial Repair After Infarction -Stem Cell Translational Medicine

    LINK

  • Honor

    -

    Top 5 Flagship R&D Achievement among Korea’s Top 30 Medical R&D Outcomes (Korea Health Industry Development Institute (KHIDI), 2025)

    Excellent Thesis Honor (Seoul National University, 2024)

    Excellent Paper Honor (Basic Science Society of the Korean Heart Association, 2024)

    Link-site

  • Scholarship

    -

    Fully Funded PhD Scholarship by the Gwanak Foundation of Seoul National University (Donor-designated)